Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.31%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.51 Down 0.04(7.22%) 10:28AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.55
Open:0.53
Bid:0.51 x 400
Ask:0.52 x 500
1y Target Est:4.00
Beta:2.13
Earnings Date:May 12 - May 18 (Est.)
Day's Range:0.50 - 0.54
52wk Range:0.50 - 1.93
Volume:253,101
Avg Vol (3m):331,221
Market Cap:14.40M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 7.22%14.40M
SNYUp 1.35%131.02B
TEVADown 0.55%52.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Mar-15) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback